Reports Q1 revenue $3.9M, consensus $3.54M. “Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating commercial engine. We believe the international regulatory clearances we secured, the clinical data we released to the neurology and stroke communities, and the continued momentum in our office and hospital businesses all indicate portable brain MRI is becoming mainstream, and we are leading the charge,” said Maria Sainz, Chief Executive Officer and President of Hyperfine (HYPR), Inc.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR:
- Hyperfine announces AIIMS New Delhi initiated clinical use of Swoop
- Hyperfine initiated with a Buy at BTIG
- Hyperfine receives CE Marking, UK Conformity Assessment approval
- Hyperfine’s Portable MRI Trial Update Puts Contrast Imaging in the Spotlight
- Horizon Technology provides $40M loan facility to Hyperfine